Disruption of the Shh pathway may play a contributory role by indirectly affecting dopaminergic and glutamatergic neurotransmission, mechanisms altered in psychosis, providing a plausible neurobiological explanation for itraconazole-related psychiatric manifestations. Here, SHH is linked to psychotic disorder.